Published in Jundishapur J Microbiol on September 18, 2016
The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2007) 3.24
Bacteriophage observations and evolution. Res Microbiol (2003) 2.77
Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol (2010) 2.51
Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol (2010) 1.92
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg Infect Dis (2003) 1.49
The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect (2006) 1.44
Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol (2005) 1.42
Bacterial and fungal colonization of burn wounds. Mem Inst Oswaldo Cruz (2005) 1.15
Biotechnological challenges of phage therapy. Biotechnol Lett (2007) 1.14
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice. Res Microbiol (2010) 0.95
Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch Virol (2011) 0.93
Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol (2010) 0.92
Bacteriophage therapy--cooked goose or phoenix rising? Curr Opin Biotechnol (2008) 0.92
Evaluation and comparison of tests to detect methicillin resistant S. aureus. Indian J Pathol Microbiol (2010) 0.89
Isolation and characterization of a Myoviridae bacteriophage against Staphylococcus aureus isolated from dairy cows with mastitis. Res Vet Sci (2013) 0.88
Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions. Expert Opin Emerg Drugs (2007) 0.87
Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiol (2009) 0.85
Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics. Appl Environ Microbiol (2012) 0.83
Genetic Polymorphism of agr Locus and Antibiotic Resistance of Staphylococcus aureus at two hospitals in Pakistan. Pak J Med Sci (2014) 0.82
Proteomic Characterization of Lytic Bacteriophages of Staphylococcus aureus Isolated from Sewage Affluent of India. Int Sch Res Notices (2014) 0.79
Essential role of calcium in the infection process of broad-spectrum methicillin-resistant Staphylococcus aureus bacteriophage. J Basic Microbiol (2013) 0.78
Antimicrobial susceptibility of Acinetobacter clinical isolates and emerging antibiogram trends for nosocomial infection management. Rev Soc Bras Med Trop (2016) 0.82
Characteristics and Antibiotic Resistance of Urinary Tract Pathogens Isolated From Punjab, Pakistan. Jundishapur J Microbiol (2015) 0.80
Bacterial munch for infants: potential pediatric therapeutic interventions of probiotics. Future Microbiol (2015) 0.77
Proteomics: Technologies and Their Applications. J Chromatogr Sci (2016) 0.75
Molecular basis of arsenite (As⁺³)-induced acute cytotoxicity in human cervical epithelial carcinoma cells. Libyan J Med (2015) 0.75
Emergence of ISAba1 harboring carbapenem-resistant Acinetobacter baumannii isolates in Pakistan. Future Microbiol (2017) 0.75